<p>The National Heart Lung and Blood Institute awarded a purchase order to Mission Bio, Inc. for $49,900 on January 24, 2020, for acquisition of a Missionbio single-cell multi-omics platform for an AML lab. Performance takes place in South San Francisco, California. The order is firm fixed price with an ultimate completion date of February 23, 2020.</p>
<p>The National Heart Lung and Blood Institute awarded a purchase order to Mission Bio, Inc. for $19,250 on July 1, 2019, for single-cell DNA sequencing library preparation materials. Work is performed in South San Francisco, California. The order is firm fixed price and carries an ultimate completion date of July 19, 2019.</p>
Mission Bio, Inc. was awarded a $39,880 purchase order by the National Heart, Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to deliver single-cell DNA protein reagent kits. The firm-fixed price order is for a one-year base period of performance beginning September 15, 2023 through September 14, 2024 in South San Francisco, California. The original solicitation sought single-cell DNA and protein reagent kits to support NHLBI's research efforts...
<p>The National Heart Lung and Blood Institute awarded a purchase order to Mission Bio, Inc. for Tapestri Single-Cell Kits valued at $26,400 on September 18, 2018. Work is performed in South San Francisco, California. The order covers single-cell DNA and protein sequencing reagent kits supporting biomedical research. Ultimate completion is November 30, 2018. The procurement was issued under a special notice without a small business set-aside.</p>
Mission Bio, Inc. has been awarded a firm fixed price purchase order valued at one hundred sixty-six thousand seven hundred twenty-nine dollars by the National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH). The contract is for a project titled "Clonal Evolution of Driver Mutations" to be performed in South San Francisco, California over a one year period concluding in August 2024. As part of the NIH's efforts to advance understanding of the...
<p>The National Heart Lung and Blood Institute awarded a purchase order to 10X Genomics, Inc. for $43,337.50 for single-cell RNA-seq technology on February 10, 2021, with a total small business set-aside designation and performance completion by March 12, 2021. Work is performed in Pleasanton, California. The order is for firm fixed price supply of single-cell genomic analysis platforms, reagents, and related consumables supporting biomedical research.</p>
The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), awarded a $34,966 firm fixed-price purchase order to Mission Bio, Inc., a for-profit manufacturer of biological supplies and sequencing services. The contract is for the delivery of Tapestri Single-Cell DNA + Protein Reagent Kits to support NHLBI's biomedical research and genomics efforts. The contract has a performance period through December 19, 2025 and does not utilize any...
<p>The National Heart Lung and Blood Institute issued a $65,338.65 delivery order to Illumina, Inc. on February 19, 2019, for Illumina reagents and consumables.</p>
<p>Place of performance is San Diego, CA 92122. The order has an ultimate completion date of September 2, 2020. Pricing is firm fixed price, with no set-aside applied.</p>
<p>The National Human Genome Research Institute awarded a purchase order to Mission Bio, Inc. valued at $20,800 on August 5, 2019. Work is performed in South San Francisco, California. The order is for single-cell genomics reagents and sequencing supplies, with firm fixed-price terms and an ultimate completion date of August 5, 2019.</p>
<p>The National Heart Lung and Blood Institute issued a $19,715.78 delivery order to Illumina, Inc. on December 9, 2026, for Illumina reagents and consumables.</p>
<p>Place of performance is San Diego, California. The order is firm fixed price with no set-aside applied. Ultimate completion date is December 9, 2019.</p>